Aiforia - Medical Image Analysis Software

With current compensation and options, one can live very well in France. How can the board still have confidence and be satisfied with a result like this? Investor money has been burned talentedly, and Tenkanen is pouring in more. Something doesn’t add up, and analysts have drastically cut their target prices. How could they be so completely wrong? If it takes time for revenue recognition, it will surely take time for implementation as well. It’s been strange storytelling over the years with no foundation based on realized figures. Just talk and hype. The share issue was held at the end of last month, and the results were known as a total bombshell before that. If I recall correctly, it was stated at the general meeting that the cash position was sufficient, and I lost my temper when the authorization for a share issue wasn’t granted. Then suddenly, an extraordinary general meeting—one can only guess the reason for the rush. Waiting for the earnings report, one has to wonder if the company’s true situation has been sugarcoated. I believe there was even a trip to France with the President, but these appearances haven’t brought in cash flow, only expenses.

12 Likes